Corinne Foo-Atkins

Dr. Corinne Foo-Atkins brings over 25 years of life sciences and medical experience to Ambys. Prior to joining Ambys, she served as Vice President, Product Strategy at NGM Biopharmaceuticals, where she established the strategic planning function for the company’s R&D portfolio across liver, cardiometabolic, oncology, and retinal diseases and led the cross-functional team for the development of aldafermin for nonalcoholic steatohepatitis. Her experience also includes research/early development project team leadership at Genentech; strategic planning, global pricing, market access, and health policy roles at Novartis; and healthcare consulting at McKinsey and Company. She received her medical degree from the National University of Singapore and was a practicing physician in Singapore’s public hospital system. In addition, she holds an MBA from the Kellogg School of Business and an MSc in Health Economics and Policy from the London School of Economics and Political Science.